Detalhe da pesquisa
1.
Sexual function and metabolic/hormonal changes in women using long-term hormonal and non-hormonal contraceptives: a pilot study.
BMC Womens Health
; 20(1): 240, 2020 10 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33109159
2.
Treatment of psoriatic arthritis with anti-TNF agents: a systematic review and meta-analysis of efficacy, effectiveness and safety.
Rheumatol Int
; 34(10): 1345-60, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24728068
3.
Treatment of ankylosing spondylitis with TNF blockers: a meta-analysis.
Rheumatol Int
; 33(9): 2199-213, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23686218
4.
Primary care in supplementary health: assessment of costs in the care of older adult patients with heart diseases.
Rev Bras Enferm
; 76(3): e20220486, 2023.
Artigo
em Inglês, Português
| MEDLINE | ID: mdl-37436234
5.
Economic evaluation of adalimumab versus etanercept for psoriatic arthritis in a Brazilian real-world model.
Expert Rev Pharmacoecon Outcomes Res
; 22(3): 473-479, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33474995
6.
The increasing burden of pancreatic cancer in Brazil from 2000 to 2019: estimates from the Global Burden of Disease Study 2019.
Rev Soc Bras Med Trop
; 55(suppl 1): e0271, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35107529
7.
Functionality assessment in patients with rheumatic diseases undergoing treatment in the Public Health System.
Einstein (Sao Paulo)
; 20: eAO6453, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35416831
8.
First-line biologic therapy with tumor necrosis factor inhibitors for psoriatic arthritis: a prospective observational study.
Sao Paulo Med J
; 140(6): 787-797, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36043662
9.
Chronic hepatitis B treatment: the cost-effectiveness of interferon compared to lamivudine.
Value Health
; 14(5 Suppl 1): S24-8, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21839893
10.
[Expenses of the Brazilian Ministry of Health for high-cost drugs: a demographic and clinical analysis]. / Gastos do Ministério da Saúde do Brasil com medicamentos de alto custo: uma análise centrada no paciente.
Value Health
; 14(5 Suppl 1): S71-7, 2011.
Artigo
em Português
| MEDLINE | ID: mdl-21839903
11.
Cost-utility analysis of the anti-TNF therapy for rheumatoid arthritis in a real-world based model.
Expert Rev Pharmacoecon Outcomes Res
; 21(5): 1011-1016, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33086882
12.
A demographic and clinical panorama of a sixteen-year cohort of soft tissue sarcoma patients in Brazil.
Sci Rep
; 11(1): 22501, 2021 11 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34795383
13.
Influence of pharmaceutical services organization on the availability of essential medicines in a public health system.
J Comp Eff Res
; 10(6): 519-532, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33739138
14.
FIRST LINE OF SUBCUTANEOUS ANTI-TNF THERAPY FOR RHEUMATOID ARTHRITIS: A PROSPECTIVE COHORT STUDY.
Expert Rev Clin Immunol
; 16(12): 1217-1225, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33203248
15.
Impact of biologic DMARDs on quality of life: 12-month results of a rheumatic diseases cohort using the Brazilian EQ-5D tariff.
Hosp Pract (1995)
; 48(4): 213-222, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32567403
16.
Biological therapy in the treatment of psoriatic arthritis: economic and epidemiological considerations.
Expert Rev Clin Immunol
; 15(8): 879-887, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31192746
17.
Access to high-cost medications for psoriatic arthritis in the National Health System in Brazil: the long path up to dispensation.
Adv Rheumatol
; 59(1): 48, 2019 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31727164
18.
First line of biological drugs in rheumatoid arthritis: a medication persistence analysis.
Expert Rev Clin Pharmacol
; 12(4): 363-370, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30813823
19.
The use of probiotics as a supplementary therapy in the treatment of patients with asthma: a pilot study and implications.
Clinics (Sao Paulo)
; 74: e950, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31411278
20.
Evaluation of Cardiovascular Risk in Climacteric Women: A Cross-Sectional Study.
J Midlife Health
; 9(3): 123-129, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30294183